BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) 

3701 Market Street
4th Floor
Philadelphia  Pennsylvania  19104  U.S.A.
Phone: 215-966-6176 Fax:


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Inovio Biomedical Corporation (INO) Closes Merger with VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) to Form a Leading Vaccine Discovery, Development and Delivery Company 6/2/2009 9:03:35 AM
Inovio Biomedical Corporation (INO)'s Registration Statement in Connection with Proposed Merger with VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Declared Effective 5/4/2009 9:21:20 AM
Inovio Biomedical Corporation (INO) and VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Extend Completion Date for Definitive Merger Agreement 4/1/2009 10:14:16 AM
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.)’ Oral Anti-Inflammatory Drug Safe in Phase I Study 3/26/2009 10:23:58 AM
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Announces Agreement With the PATH Malaria Vaccine Initiative 3/23/2009 10:00:24 AM
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Avian Influenza DNA Vaccine Delivered with Electroporation Provides 100% Protection of Non-Human Primates 2/23/2009 11:34:43 AM
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Proprietary DNA Vaccines Delivered with Electroporation Achieve Immune Responses Superior to Recombinant Adenovirus Serotype 5 (Ad5) Vectors 2/18/2009 9:44:54 AM
VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Announces Filing of Device Master File Amendment with the FDA for CELLECTRA Device – Intradermal Electroporation (ID-EP) 2/13/2009 10:54:27 AM
Inovio Biomedical Corporation (INO) and VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) Amend Merger Agreement 12/8/2008 10:55:10 AM
Inovio Biomedical Corporation (INO) and VGX Pharmaceuticals (Formerly Known as Viral Genomix, Inc.) to Highlight Recent Advances in Electroporation-Delivered DVA Vaccines at International DNA Vaccines Conference 12/4/2008 9:28:14 AM
12345